Additional file 2. Table S1. Relationships between sRAGE, NEWS2 and IL-6. Table S2. Univariate analysis for potential predictors of mortality in dexamethasone-treated COVID-19 patients. Table S3. Performance of sRAGE and NEWS2 in their ability to predict mortality in dexamethasone-treated COVID-19 patient
International audienceDexamethasone has demonstrated efficacy in reducing mortality in COVID-19. How...
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory diseas...
The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (D...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
In the manuscript "Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, pr...
BackgroundThe success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of...
BackgroundDexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen th...
BackgroundThe value of the soluble receptor for advanced glycation end-products (sRAGE) as a biomark...
Additional file 1 Table S1 List of drugs prescribed, frequency of prescription, and proportion of pa...
OBJECTIVES:. To identify and characterize clinical decline after completion of dexamethasone in seve...
International audienceRationale. Although soluble forms of the receptor for advanced glycation end p...
Additional file 5: Table S1. Medications and conditions used to stratify Mild versus Moderate/Severe...
Introduction: Coronavirus disease-2019 (COVID-19) with lung involvement frequently causes morbidity ...
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory diseas...
International audienceDexamethasone has demonstrated efficacy in reducing mortality in COVID-19. How...
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory diseas...
The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (D...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
In the manuscript "Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, pr...
BackgroundThe success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of...
BackgroundDexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen th...
BackgroundThe value of the soluble receptor for advanced glycation end-products (sRAGE) as a biomark...
Additional file 1 Table S1 List of drugs prescribed, frequency of prescription, and proportion of pa...
OBJECTIVES:. To identify and characterize clinical decline after completion of dexamethasone in seve...
International audienceRationale. Although soluble forms of the receptor for advanced glycation end p...
Additional file 5: Table S1. Medications and conditions used to stratify Mild versus Moderate/Severe...
Introduction: Coronavirus disease-2019 (COVID-19) with lung involvement frequently causes morbidity ...
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory diseas...
International audienceDexamethasone has demonstrated efficacy in reducing mortality in COVID-19. How...
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory diseas...
The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (D...